Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas

PURPOSE: Numerous preclinical studies demonstrate that angiogenesis inhibitors can increase the efficacy of radiation therapy (RT). We sought to examine safety and efficacy of bevacizumab (BV) and RT in soft tissue sarcomas (STS) and explore biomarkers for treatment response. METHODS AND MATERIALS:...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Yoon, Sam S., Duda, Dan G., Karl, Daniel L., Kim, Tae-Min, Kambadakone, Avinash R., Chen, Yen-Lin, Rothrock, Courtney, Rosenberg, Andrew E., Nielsen, G. Petur, Kirsch, David G., Choy, Edwin, Harmon, David C, Hornicek, Francis J., Dreyfuss, Jonathan, Ancukiewicz, Marek, Sahani, Dushyant V., Park, Peter J., Jain, Rakesh K., DeLaney, Thomas F.
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021107/
https://ncbi.nlm.nih.gov/pubmed/20932656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.07.024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы